Publicaciones en colaboración con investigadores/as de University College London (12)

2023

  1. Advanced MR Techniques for Preoperative Glioma Characterization: Part 1

    Journal of Magnetic Resonance Imaging, Vol. 57, Núm. 6, pp. 1655-1675

  2. Advanced MR Techniques for Preoperative Glioma Characterization: Part 2

    Journal of Magnetic Resonance Imaging, Vol. 57, Núm. 6, pp. 1676-1695

2019

  1. Post hoc analysis of the Exenatide-PD trial—Factors that predict response

    European Journal of Neuroscience, Vol. 49, Núm. 3, pp. 410-421

2018

  1. Arterial spin labelling MRI to measure renal perfusion: a systematic review and statement paper

    Nephrology Dialysis Transplantation, Vol. 33, pp. II15-II21

  2. Transcriptomic integration of D4R and MOR signaling in the rat caudate putamen

    Scientific Reports, Vol. 8, Núm. 1

  3. What effects might exenatide have on non-motor symptoms in Parkinson's disease: A post Hoc analysis

    Journal of Parkinson's Disease, Vol. 8, Núm. 2, pp. 247-258

2017

  1. Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration

    Movement Disorders Clinical Practice, Vol. 4, Núm. 4, pp. 536-544

  2. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

    The Lancet, Vol. 390, Núm. 10103, pp. 1664-1675

2015

  1. Motor and Cognitive Advantages Persist 12 Months after Exenatide Exposure in Parkinson's Disease

    Journal of Parkinson's Disease, Vol. 4, Núm. 3, pp. 337-344

2013

  1. Exenatide and the treatment of patients with Parkinson's disease

    Journal of Clinical Investigation, Vol. 123, Núm. 6, pp. 2730-2736

  2. Suicidal ideation in a European Huntington's disease population

    Journal of Affective Disorders, Vol. 151, Núm. 1, pp. 248-258

2006

  1. Improving whole brain structural MRI at 4.7 Tesla using 4 irregularly shaped receiver coils

    NeuroImage, Vol. 32, Núm. 3, pp. 1176-1184